Literature DB >> 11884535

Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors.

Sapna Sinha1, Michael H Pursley, Duane P Grandgenett.   

Abstract

Replication of retroviruses requires integration of the linear viral DNA genome into the host chromosomes. Integration requires the viral integrase (IN), located in high-molecular-weight nucleoprotein complexes termed preintegration complexes (PIC). The PIC inserts the two viral DNA termini in a concerted manner into chromosomes in vivo as well as exogenous target DNA in vitro. We reconstituted nucleoprotein complexes capable of efficient concerted (full-site) integration using recombinant wild-type human immunodeficiency virus type I (HIV-1) IN with linear retrovirus-like donor DNA (480 bp). In addition, no cellular or viral protein cofactors are necessary for purified bacterial recombinant HIV-1 IN to mediate efficient full-site integration of two donor termini into supercoiled target DNA. At about 30 nM IN (20 min at 37 degrees C), approximately 15 and 8% of the input donor is incorporated into target DNA, producing half-site (insertion of one viral DNA end per target) and full-site integration products, respectively. Sequencing the donor-target junctions of full-site recombinants confirms that 5-bp host site duplications have occurred with a fidelity of about 70%, similar to the fidelity when using IN derived from nonionic detergent lysates of HIV-1 virions. A key factor allowing recombinant wild-type HIV-1 IN to mediate full-site integration appears to be the avoidance of high IN concentrations in its purification (about 125 microg/ml) and in the integration assay (<50 nM). The results show that recombinant HIV-1 IN may not be significantly defective for full-site integration. The findings further suggest that a high concentration or possibly aggregation of IN is detrimental to the assembly of correct nucleoprotein complexes for full-site integration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884535      PMCID: PMC136053          DOI: 10.1128/jvi.76.7.3105-3113.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  DNase protection analysis of retrovirus integrase at the viral DNA ends for full-site integration in vitro.

Authors:  A Vora; D P Grandgenett
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 2.  HIV integrase, a brief overview from chemistry to therapeutics.

Authors:  R Craigie
Journal:  J Biol Chem       Date:  2001-05-09       Impact factor: 5.157

3.  Correct integration of retroviral DNA in vitro.

Authors:  P O Brown; B Bowerman; H E Varmus; J M Bishop
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

4.  Base-pair substitutions in avian sarcoma virus U5 and U3 long terminal repeat sequences alter the process of DNA integration in vitro.

Authors:  P Hindmarsh; M Johnson; R Reeves; J Leis
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  A colorimetric method for the determination of submicrogram quantities of protein.

Authors:  G S McKnight
Journal:  Anal Biochem       Date:  1977-03       Impact factor: 3.365

6.  Oligomeric states of the HIV-1 integrase as measured by time-resolved fluorescence anisotropy.

Authors:  E Deprez; P Tauc; H Leh; J F Mouscadet; C Auclair; J C Brochon
Journal:  Biochemistry       Date:  2000-08-08       Impact factor: 3.162

7.  Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity.

Authors:  P A Sherman; J A Fyfe
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

8.  Effect of Escherichia coli chaperonin GroELS on heterologously expressed human immunodeficiency virus type 1 reverse transcriptase in vivo and in vitro.

Authors:  G Maier; E Manakova; H Heumann
Journal:  Appl Biochem Biotechnol       Date:  2000-05       Impact factor: 2.926

9.  GroE heat-shock proteins promote assembly of foreign prokaryotic ribulose bisphosphate carboxylase oligomers in Escherichia coli.

Authors:  P Goloubinoff; A A Gatenby; G H Lorimer
Journal:  Nature       Date:  1989-01-05       Impact factor: 49.962

10.  Structure-based mutagenesis of the human immunodeficiency virus type 1 DNA attachment site: effects on integration and cDNA synthesis.

Authors:  H E Brown; H Chen; A Engelman
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

View more
  50 in total

1.  Cofactors for human immunodeficiency virus type 1 cDNA integration in vitro.

Authors:  Kui Gao; Robert J Gorelick; Donald G Johnson; Frederic Bushman
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 2.  HIV DNA integration.

Authors:  Robert Craigie; Frederic D Bushman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  Clinical Use of Inhibitors of HIV-1 Integration: Problems and Prospects.

Authors:  S P Korolev; Yu Yu Agapkina; M B Gottikh
Journal:  Acta Naturae       Date:  2011-07       Impact factor: 1.845

Review 4.  Authentic HIV-1 integrase inhibitors.

Authors:  Chenzhong Liao; Christophe Marchand; Terrence R Burke; Yves Pommier; Marc C Nicklaus
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

5.  Subunit-specific protein footprinting reveals significant structural rearrangements and a role for N-terminal Lys-14 of HIV-1 Integrase during viral DNA binding.

Authors:  Zhuojun Zhao; Christopher J McKee; Jacques J Kessl; Webster L Santos; Janet E Daigle; Alan Engelman; Gregory Verdine; Mamuka Kvaratskhelia
Journal:  J Biol Chem       Date:  2007-12-19       Impact factor: 5.157

6.  Retroviral DNA integration: reaction pathway and critical intermediates.

Authors:  Min Li; Michiyo Mizuuchi; Terrence R Burke; Robert Craigie
Journal:  EMBO J       Date:  2006-02-16       Impact factor: 11.598

7.  Nucleoprotein complex intermediates in HIV-1 integration.

Authors:  Min Li; Robert Craigie
Journal:  Methods       Date:  2009-02-20       Impact factor: 3.608

8.  Differential multimerization of Moloney murine leukemia virus integrase purified under nondenaturing conditions.

Authors:  Rodrigo A Villanueva; Colleen B Jonsson; Jennifer Jones; Millie M Georgiadis; Monica J Roth
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

9.  The (52-96) C-terminal domain of Vpr stimulates HIV-1 IN-mediated homologous strand transfer of mini-viral DNA.

Authors:  Julien Bischerour; Patrick Tauc; Hervé Leh; Hugues de Rocquigny; Bernard Roques; Jean-François Mouscadet
Journal:  Nucleic Acids Res       Date:  2003-05-15       Impact factor: 16.971

Review 10.  Virological and cellular roles of the transcriptional coactivator LEDGF/p75.

Authors:  Manuel Llano; James Morrison; Eric M Poeschla
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.